Trials / Completed
CompletedNCT04920123
Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic
Towards the Development of a Mobile-health Technology Designed to Encourage the Use of Serious Game-based Interventions in Patients With Mild Cognitive Impairment Outside the Clinic
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- University of Massachusetts, Amherst · Academic / Other
- Sex
- All
- Age
- 55 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the therapeutic efficacy of Neuro-World cognitive training games (Woorisoft, S. Korea) in patients with mild cognitive impairment.
Detailed description
This study will be a cross-over randomized controlled trial. Fifty participants will be enrolled and randomly assigned to group A or group B. Group A will self-administer Neuro-World cognitive training games for 30 minutes a day, twice a week for 12 weeks in the home setting (i.e., intervention period). For the following 12 weeks, the participants will not engage in any therapist-supervised cognitive therapies (i.e., no-intervention period). Group B will not engage in any therapist-supervised cognitive therapies (i.e., no-intervention period). For the following 12 weeks, the participants will self-administer Neuro-World cognitive training games for 30 minutes a day, twice a week in the home setting (i.e., intervention period). All the participants in both groups will receive phone calls twice a week to 1) provide feedback on their adherence to Neuro-World cognitive training (during the intervention period) and 2) learn any significant changes in the level of their daily activities (during the no-intervention period and the intervention period).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Neuro-World | Neuro-World is a collection of six games that are developed for cognitive training that focuses on memory and attention. |
Timeline
- Start date
- 2022-02-17
- Primary completion
- 2025-03-31
- Completion
- 2025-03-31
- First posted
- 2021-06-09
- Last updated
- 2025-08-07
- Results posted
- 2025-08-07
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04920123. Inclusion in this directory is not an endorsement.